+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Fecal Occult Testing Market 2020-2024 - Product Image

Global Fecal Occult Testing Market 2020-2024

  • ID: 4894522
  • Report
  • May 2020
  • Region: Global
  • 120 pages
  • TechNavio

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Biohit Oyj
  • bioMérieux SA
  • Danaher Corp.
  • Eiken Chemical Co. Ltd.
  • Epigenomics AG
  • MORE
Global Fecal Occult Testing Market 2020-2024

The fecal occult testing market is poised to grow by $ 75.15 million during 2020-2024 progressing at a CAGR of 4% during the forecast period. The reports on fecal occult testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising geriatric population and increasing prevalence of CRC. In addition, rising geriatric population is anticipated to boost the growth of the market as well.

The fecal occult testing market market analysis includes end-user segment and geographic landscapes.

The fecal occult testing market is segmented as below:

By End User
  • Hospitals
  • Clinical diagnostic laboratories
By Geographic Landscapes
  • North America
  • Europe
  • APAC
  • South America
  • MEA
This study identifies the increasing number of government initiatives for CRC screening tests as one of the prime reasons driving the fecal occult testing market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The fecal occult testing market covers the following areas:
  • Fecal occult testing market sizing
  • Fecal occult testing market forecast
  • Fecal occult testing market industry analysis.
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fecal occult testing market vendors that include Abbott Laboratories, Biohit Oyj, bioMérieux SA, Danaher Corp., Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corp., Quest Diagnostics Inc., Quidel Corp., and Siemens Healthineers AG. Also, the fecal occult testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Biohit Oyj
  • bioMérieux SA
  • Danaher Corp.
  • Eiken Chemical Co. Ltd.
  • Epigenomics AG
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by End-user
  • Market segments
  • Comparison by End-user
  • Hospitals - Market size and forecast 2019-2024
  • Physicians' office laboratories - Market size and forecast 2019-2024
  • Clinical diagnostic laboratories - Market size and forecast 2019-2024
  • Market opportunity by End-user
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Biohit Oyj
  • bioMérieux SA
  • Danaher Corp.
  • Eiken Chemical Co. Ltd.
  • Epigenomics AG
  • Exact Sciences Corp.
  • Quest Diagnostics Inc.
  • Quidel Corp.
  • Siemens Healthineers AG
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: End user - Market share 2019-2024 (%)
22: Comparison by End user
23: Hospitals - Market size and forecast 2019-2024 ($ million)
24: Hospitals - Year-over-year growth 2019-2024 (%)
25: Clinical diagnostic laboratories - Market size and forecast 2019-2024 ($ million)
26: Clinical diagnostic laboratories - Year-over-year growth 2019-2024 (%)
27: Market opportunity by End user
28: Customer landscape
29: Market share by geography 2019-2024 (%)
30: Geographic comparison
31: North America - Market size and forecast 2019-2024 ($ million)
32: North America - Year-over-year growth 2019-2024 (%)
33: Europe - Market size and forecast 2019-2024 ($ million)
34: Europe - Year-over-year growth 2019-2024 (%)
35: APAC - Market size and forecast 2019-2024 ($ million)
36: APAC - Year-over-year growth 2019-2024 (%)
37: South America - Market size and forecast 2019-2024 ($ million)
38: South America - Year-over-year growth 2019-2024 (%)
39: MEA - Market size and forecast 2019-2024 ($ million)
40: MEA - Year-over-year growth 2019-2024 (%)
41: Key leading countries
42: Market opportunity by geography ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: Abbott Laboratories - Overview
50: Abbott Laboratories - Business segments
51: Abbott Laboratories - Key offerings
52: Abbott Laboratories - Key customers
53: Abbott Laboratories - Segment focus
54: Biohit Oyj - Overview
55: Biohit Oyj - Business segments
56: Biohit Oyj - Key offerings
57: Biohit Oyj - Key customers
58: Biohit Oyj - Segment focus
59: bioMérieux SA - Overview
60: bioMérieux SA - Business segments
61: bioMérieux SA - Key offerings
62: bioMérieux SA - Key customers
63: bioMérieux SA - Segment focus
64: Danaher Corp. - Overview
65: Danaher Corp. - Business segments
66: Danaher Corp. - Key offerings
67: Danaher Corp. - Key customers
68: Danaher Corp. - Segment focus
69: Eiken Chemical Co. Ltd. - Overview
70: Eiken Chemical Co. Ltd. - Business segments
71: Eiken Chemical Co. Ltd. - Key offerings
72: Eiken Chemical Co. Ltd. - Key customers
73: Eiken Chemical Co. Ltd. - Segment focus
74: Epigenomics AG - Overview
75: Epigenomics AG - Business segments
76: Epigenomics AG - Key offerings
77: Epigenomics AG - Key customers
78: Epigenomics AG - Segment focus
79: Exact Sciences Corp. - Overview
80: Exact Sciences Corp. - Business segments
81: Exact Sciences Corp. - Key offerings
82: Exact Sciences Corp. - Key customers
83: Exact Sciences Corp. - Segment focus
84: Quest Diagnostics Inc. - Overview
85: Quest Diagnostics Inc. - Business segments
86: Quest Diagnostics Inc. - Key offerings
87: Quest Diagnostics Inc. - Key customers
88: Quest Diagnostics Inc. - Segment focus
89: Quidel Corp. - Overview
90: Quidel Corp. - Business segments
91: Quidel Corp. - Key offerings
92: Quidel Corp. - Key customers
93: Quidel Corp. - Segment focus
94: Siemens Healthineers AG - Overview
95: Siemens Healthineers AG - Business segments
96: Siemens Healthineers AG - Key offerings
97: Siemens Healthineers AG - Key customers
98: Siemens Healthineers AG - Segment focus
99: Currency conversion rates for US$
100: Research Methodology
101: Validation techniques employed for market sizing
102: Information sources
103: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Biohit Oyj
  • bioMérieux SA
  • Danaher Corp.
  • Eiken Chemical Co. Ltd.
  • Epigenomics AG
  • MORE
The publisher recognizes the following companies as the key players in the global fecal occult testing market: Abbott Laboratories, Biohit Oyj, bioMérieux SA, Danaher Corp., Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corp., Quest Diagnostics Inc., Quidel Corp., and Siemens Healthineers AG.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of government initiatives for CRC screening tests."

According to the report, one of the major drivers for this market is the rising geriatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Biohit Oyj
  • bioMérieux SA
  • Danaher Corp.
  • Eiken Chemical Co. Ltd.
  • Epigenomics AG
  • Exact Sciences Corp.
  • Quest Diagnostics Inc.
  • Quidel Corp.
  • Siemens Healthineers AG.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll